InvestorsHub Logo
Followers 13
Posts 559
Boards Moderated 0
Alias Born 12/31/2012

Re: Whos_Who post# 677

Friday, 05/26/2017 12:25:03 AM

Friday, May 26, 2017 12:25:03 AM

Post# of 3061
"Clearly, the delivery technology and formulation of BPX-01 is intriguing and avoids many of the pitfalls of current treatments. BPX-01 fully solubilizes minocycline, increasing the efficiency of antibiotic delivery and allowing for effective topical delivery at doses much lower than oral antibiotics.

The gel is non-oily, non-staining and leaves no residue. It has demonstrated high penetration and targeted delivery of minocycline directly through the skin at the site where acne develops. It has a dual benefit of anti-bacterial and anti-inflammatory properties and a lower resistance rate than other antibiotics. By combining the efficacy of an antibiotic, the benefits of targeted application through topical delivery, and by minimizing the side effects associated with both, BPX-01 promises to be a new safe and effective option for the millions of people with moderate-to-severe acne."

Thanks for the link Whos Who.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.